Vacuolar ATPase-mediated sequestration of local anesthetics in swollen macroautophagosomes

Canadian Journal of Anesthesia

Volumn 57, Issue 3, 2010, Pages 230-239

  Bawolak, Marie Thérèse ^a   Morissette, Guillaume ^a   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLADENINE; ADENOSINE TRIPHOSPHATASE; BAFILOMYCIN A1; CD63 ANTIGEN; CELL PROTEIN; GREEN FLUORESCENT PROTEIN; LIDOCAINE; LOCAL ANESTHETIC AGENT; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROCAINE; PROTEIN KINASE B; PROTEIN LC3; PROTEIN P53; RAB7 PROTEIN; UNCLASSIFIED DRUG; VACUOLAR ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CELL LABELING; CELL PROLIFERATION; CELL VACUOLE; CELL VACUOLIZATION; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; CYTOTOXICITY; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER;

ADENOSINE TRIPHOSPHATASES; ANESTHETICS, LOCAL; ANIMALS; ANTHRACENES; AUTOPHAGY; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOBLOTTING; LIDOCAINE; MACROPHAGES; MYOCYTES, SMOOTH MUSCLE; PHAGOSOMES; PROCAINE; RABBITS; VACUOLAR PROTON-TRANSLOCATING ATPASES; VACUOLES;

EID: 77953285216     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12630-009-9220-9     Document Type: Article

References (37)

1. Catterall W, Mackie K. Local anesthetics. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. McGraw-Hill: New York; 2006. p. 369-86.
2. Kim T, Holley GP, Lee JH, Broocker G, Edelhauser HF. The effects of intraocular lidocaine on the corneal endothelium. Ophthalmology 1998; 105: 125-30.
3. Anderson NJ, Nath R, Anderson CJ, Edelhauser HF. Comparison of preservative-free bupivacaine vs. lidocaine for intracameral anesthesia: a randomized clinical trial and in vitro analysis. Am J Ophthalmol 1999; 127: 393-402.
4. Atilla H, Tekeli O, Can B, Karel F, Saran Y. Effects of intracameral lidocaine on ocular tissues. Clin Experiment Ophthalmol 2003; 31: 73-7.
5. Cakmak SS, Olmez G, Nergiz Y, Unlu K, Soker S. The effect of intracameral ropivacaine on the corneal endothelium. Jpn J Ophthalmol 2005; 49: 267-8.
6. Hoss DM, Gross EG, Grant-Kels JM. Histopathology of an adverse reaction to a eutectic mixture of the local anesthetics lidocaine and prilocaine. J Cutan Pathol 1999; 26: 100-4.
7. Vallance H, Chaba T, Clarke L, Taylor G. Pseudo-lysosomal storage disease caused by EMLA cream. J Inherit Metab Dis 2004; 27: 507-11.
8. Cazes A, Prost-Squarcioni C, Bodemer C, Heller M, Brousse N, Fraitag S. Histologic cutaneous modifications after the use of EMLA cream, a diagnostic pitfall: review of 13 cases. Arch Dermatol 2007; 143: 1074-6.
9. Miller K, Foster JR. Evidence of transient effect by lignocaine on alveolar macrophage morphology. J Immunol Methods 1981; 43: 163-8.
10. Michalik M, Pierzchalska M, Pabianczyk-Kulka A, Korohoda W. Procaine-induced enhancement of fluid-phase endocytosis and inhibition of exocytosis in human skin fibroblasts. Eur J Pharmacol 2003; 475: 1-10.
11. Morissette G, Moreau E, C-Gaudreault R, Marceau F. Massive cell vacuolization induced by organic amines such as procainamide. J Pharmacol Exp Ther 2004; 310: 395-406.
12. Morissette G, Moreau E, C-Gaudreault R, Marceau F. N-sub-stituted 4-aminobenzamides (procainamide analogs): an assessment of multiple cellular effects concerning ion trapping. Mol Pharmacol 2005; 68: 1576-89.
13. Morissette G, Bouthillier J, Marceau F. Trapping of adrenergic decongestant drugs into cellular endomembrane compartments: toxicological and pharmacological consequences. Int Immunopharmacol 2007; 7: 1869-79.
14. Morissette G, Germain L, Marceau F. The antiwrinkle effect of topical concentrated 2-dimethylaminoethanol involves a vacuolar cytopathology. Br J Dermatol 2007; 156: 433-9.
15. Morissette G, Lodge R, Marceau F. Intense pseudotransport of a cationic drug mediated by vacuolar ATPase: procainamideinduced autophagic cell vacuolization. Toxicol Appl Pharmacol 2008; 228: 364-77.
16. Morissette G, Lodge R, Bouthillier J, Marceau F. Receptor-independent, vacuolar ATPase-mediated cellular uptake of histamine receptor-1 ligands: possible origin of pharmacological distortions and side effects. Toxicol Appl Pharmacol 2008; 229: 320-31.
17. 1 angiotensin receptor. J Cell Biol 2002; 157: 1211-22.
18. Kabeya Y, Mizushima N, Ueno T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720-8.
19. Morissette G, Marceau F. Ô miroir, dis-moi comment les amines effacent les rides: la cytopathologie vacuolaire médiée par la VATPase. Med Sci (Paris) 2007; 23: 579-80.
20. Munro S, Nichols BJ. The GRIP domain - a novel Golgi-targeting domain found in several coiled-coil proteins. Curr Biol 1999; 9: 377-80.
21. Jain RK, Joyce PB, Molinete M, Halban PA, Gorr SU. Oligomerization of green fluorescent protein in the secretory pathway of the endocrine cells. Biochem J 2001; 360: 645-9.
22. Falcón-Pérez JM, Nazarian R, Sabatti C, Dell'Angelica EC. Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 2005; 118: 5243-55.
23. Maiuri MC, Zalckvar E, Kimchi A, Kroemer G. Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 2007; 8: 741-52.
24. Gould GW, Cuenda A, Thomson FJ, Cohen P. The activation of distinct mitogen-activated protein kinase cascades is required for the stimulation of 2-deoxyglucose uptake by interleukin-1 and insulinlike growth factor-1 in KB cells. Biochem J 1995; 311: 735-8.
25. Mörch ET, Rosenberg MK, Truant AT. Lidocaine for spinal anesthesia. A study of the concentration in the spinal fluid. Acta Anaesthesiol Scand 2007; 51: 1005-15.
26. Gammaitoni AR, Alvarez NA, Galer BS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 2003; 43: 111-7.
27. Robins P, Ashinoff R. Prolongation of anesthesia in Mohs micrographic surgery with 2% lidocaine jelly. J Dermatol Surg Oncol 1991; 17: 649-52.
28. +-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drugresistant renal epithelial cells. Biochem J 2003; 370: 185-93.
29. Zhang X, Zheng N, Rosania GR. Simulation-based cheminformatic analysis of organelle-targeted molecules: lysosomotropic monobasic amines. J Comput Aided Mol Des 2008; 22: 629-45.
30. +-ATPase in vesicular trafficking: targeting, regulation and function. Curr Opin Cell Biol 2008; 20: 415-26.
31. Jäger S, Bucci C, Tanida I, et al. Role of Rab7 in maturation of late autophagic vacuoles. J Cell Sci 2004; 117: 4837-48.
32. Gutierrez MG, Mufano DB, Beron W, Colombo MI. Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J Cell Sci 2004; 117: 2687-97.
33. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 1994; 265: 808-11.
34. Wallace KB. Mitochondrial off targets of drug therapy. Trends Pharmacol Sci 2008; 29: 361-6.
35. Johnson ME, Uhl CB, Spittler KH, Wang H, Gores GJ. Mitochondrial injury and caspase activation by the local anesthetic lidocaine. Anesthesiology 2004; 101: 1184-94.
36. Werdehausen R, Braun S, Essmann F, et al. Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling. Anesthesiology 2007; 107: 136-43.
37. Perez-Castro R, Patel S, Garavito-Aguilar ZV, et al. Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg 2009; 108: 997-1007.